Exploring the Potential of Anthraquinone-Based Hybrids for Identifying a Novel Generation of Antagonists for the Smoothened Receptor in HH-Dependent Tumour.


Journal

Chemistry (Weinheim an der Bergstrasse, Germany)
ISSN: 1521-3765
Titre abrégé: Chemistry
Pays: Germany
ID NLM: 9513783

Informations de publication

Date de publication:
08 Nov 2023
Historique:
received: 13 07 2023
medline: 10 11 2023
pubmed: 11 8 2023
entrez: 11 8 2023
Statut: ppublish

Résumé

Natural products (NPs) are highly profitable pharmacological tools due to their chemical diversity and ability to modulate biological systems. Accessing new chemical entities while retaining the biological relevance of natural chemotypes is a fundamental goal in the design of novel bioactive compounds. Notably, NPs have played a crucial role in understanding Hedgehog (HH) signalling and its pharmacological modulation in anticancer therapy. However, HH antagonists developed so far have shown several limitations, thus growing interest in the design of second-generation HH inhibitors. Through smart manipulation of the NPs core-scaffold, unprecedented and intriguing architectures have been achieved following different design strategies. This study reports the rational design and synthesis of a first and second generation of anthraquinone-based hybrids by combining the rhein scaffold with variously substituted piperazine nuclei that are structurally similar to the active portion of known SMO antagonists, the main transducer of the HH pathway. A thorough functional and biological investigation identified RH2_2 and RH2_6 rhein-based hybrids as valuable candidates for HH inhibition through SMO antagonism, with the consequent suppression of HH-dependent tumour growth. These findings also corroborated the successful application of the NPs-based hybrid design strategy in the development of novel NP-based SMO antagonists.

Identifiants

pubmed: 37565343
doi: 10.1002/chem.202302237
doi:

Substances chimiques

Smoothened Receptor 0
rhein YM64C2P6UX
Hedgehog Proteins 0
Antineoplastic Agents 0
Anthraquinones 0
9,10-anthraquinone 030MS0JBDO
Receptors, G-Protein-Coupled 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e202302237

Subventions

Organisme : Ministero dell'Istruzione, dell'Università e della Ricerca
ID : PRIN 2017BF3PXZ003
Organisme : Associazione Italiana per la Ricerca sul Cancro
ID : #IG20801
Organisme : Associazione Italiana per la Ricerca sul Cancro
ID : MFAG 2021-ID. 26536

Informations de copyright

© 2023 The Authors. Chemistry - A European Journal published by Wiley-VCH GmbH.

Références

A. G. Atanasov, S. B. Zotchev, V. M. Dirsch, C. T. Supuran, Nat. Rev. Drug Discovery 2021, 20 (3), 200-216.
D. J. Newman, G. M. Cragg, J. Nat. Prod. 2020, 83 (3), 770-803.
https://gco.iarc.fr/today/data/factsheets/populations/900-world-fact-sheets.pdf.
Y. Li, Z. Wang, J. A. Ajani, S. Song, Cell Commun. Signaling 2021, 19 (1), 19.
J. D. Ebben, D. M. Treisman, M. Zorniak, R. G. Kutty, P. A. Clark, J. S. Kuo, Expert Opin. Ther. Targets 2010, 14 (6), 621-632.
C. Bichakjian, A. Armstrong, C. Baum, J. S. Bordeaux, M. Brown, K. J. Busam, D. B. Eisen, V. Iyengar, C. Lober, D. J. J. J. o. t. A. A. o. D. Margolis, Journal of the American Academy of Dermatology 2018, 78 (3), 540-559.
F. Ghirga, M. Mori, P. J. Infante, Bioorg. Med. Chem. Lett. 2018, 28 (19), 3131-3140.
D. Girardi, A. Barrichello, G. Fernandes, A. Pereira, Cells 2019, 8 (2), 153.
P. Infante, R. Faedda, F. Bernardi, F. Bufalieri, L. Lospinoso Severini, R. Alfonsi, D. Mazzà, M. Siler, S. Coni, A. Po, Nat. Commun. 2018, 9 (1), 976.
L. Lospinoso Severini, F. Ghirga, F. Bufalieri, D. Quaglio, P. Infante, L. Di Marcotullio, Expert Opin. Ther. Targets 2020, 24 (11), 1159-1181.
P. A. Northcott, G. W. Robinson, C. P. Kratz, D. J. Mabbott, S. L. Pomeroy, S. C. Clifford, S. Rutkowski, D. W. Ellison, D. Malkin, M. D. Taylor, A. Gajjar, S. M. Pfister, Nat. Rev. Dis. Primers 2019, 5 (1), 11.
D. Quaglio, P. Infante, L. Di Marcotullio, B. Botta, M. Mori, Expert Opin. Ther. Pat. 2020, 30 (4), 235-250.
S. X. Atwood, K. Y. Sarin, R. J. Whitson, J. R. Li, G. Kim, M. Rezaee, M. S. Ally, J. Kim, C. Yao, A. L. S. Chang, A. E. Oro, J. Y. Tang, Cancer Cell 2015, 27 (3), 342-353.
C. Danial, K. Y. Sarin, A. E. Oro, A. L. S. Chang, Clin. Cancer Res. 2016, 22 (6), 1325-1329.
J. George, Y. Chen, N. Abdelfattah, K. Yamamoto, T. D. Gallup, S. I. Adamson, B. Rybinski, A. Srivastava, P. Kumar, M. G. Lee, Cancer Res. Commun. 2022, 2 (6), 402-416.
H. Q. Doan, L. Chen, Z. Nawas, H.-H. Lee, S. Silapunt, M. Migden, Oncotarget 2021, 12 (20), 2089.
N. M. Nguyen, J. Cho, Int. J. Molec. Sci. 2022, 23 (3), 1733.
J. K. Chen, Nat. Prod. Rep. 2016, 33 (5), 595-601.
R. Palermo, F. Ghirga, M. G. Piccioni, F. Bernardi, N. Zhdanovskaya, P. Infante, M. Mori, Curr. Pharm. Des. 2018, 24 (36), 4251-4269.
C. Bao, P. Kramata, H. J. Lee, N. J. Suh, Mol. Nutr. Food Res. 2018, 62 (1), 1700621.
E. A. Crane, K. Gademann, Angew. Chem. Int. Ed. 2016, 55 (12), 3882-3902.
G. S. Cremosnik, J. Liu, H. Waldmann, Nat. Prod. Rep. 2020, 37 (11), 1497-1510.
M. Grigalunas, S. Patil, A. Krzyzanowski, A. Pahl, J. Flegel, B. Schölermann, J. Xie, S. Sievers, S. Ziegler, H. Waldmann, Chem. Eur. J. 2022, 28 (67), e202202164.
G. Karageorgis, D. J. Foley, L. Laraia, H. Waldmann, Nat. Chem. 2020, 12 (3), 227-235.
L. Laraia, G. Garivet, D. J. Foley, N. Kaiser, S. Müller, S. Zinken, T. Pinkert, J. Wilke, D. Corkery, A. Pahl, Angew. Chem. Int. Ed. 2020, 59 (14), 5721-5729.
K. C. Morrison, P. J. Hergenrother, Nat. Prod. Rep. 2013, 31 (1), 6-14.
S. Wetzel, R. S. Bon, K. Kumar, H. Waldmann, Angew. Chem. Int. Ed. 2011, 50 (46), 10800-10826.
G. Liu, D. Xue, J. Yang, J. Wang, X. Liu, W. Huang, J. Li, Y.-Q. Long, W. Tan, A. Zhang, J. Med. Chem. 2016, 59 (24), 11050-11068.
E. Sflakidou, G. Leonidis, E. Foroglou, C. Siokatas, V. Sarli, Molecules 2022, 27 (19), 6632.
E. M. Malik, C. E. Müller, Med. Res. Rev. 2016, 36 (4), 705-748.
T. Narender, P. Sukanya, K. Sharma, S. R. Bathula, Phytomedicine 2013, 20 (10), 890-896.
A. S. Tikhomirov, A. A. Shtil, A. E. Shchekotikhin, Recent Pat. Anti-Infect. Drug Discovery 2018, 13 (2), 159-183.
S. Ciaco, V. Mazzoleni, A. Javed, S. Eiler, M. Ruff, M. Mousli, M. Mori, Y. Mély, Bioorg. Chem. 2023, 137, 106616.
L. Zaayter, M. Mori, T. Ahmad, W. Ashraf, C. Boudier, V. Kilin, K. Gavvala, L. Richert, S. Eiler, M. Ruff, M. Botta, C. Bronner, M. Mousli, Y. Mély, Chem. Eur. J. 2019, 25 (58), 13363-13375.
M. Sebak, F. Molham, C. Greco, M. A. Tammam, M. Sobeh, A. El-Demerdash, RSC Adv. 2022, 12 (38), 24887-24921.
R. B. Semwal, D. K. Semwal, S. Combrinck, A. Viljoen, Phytochemistry 2021, 190, 112854.
L. Lospinoso Severini, D. Quaglio, I. Basili, F. Ghirga, F. Bufalieri, M. Caimano, S. Balducci, M. Moretti, I. Romeo, E. Loricchio, Cancers 2019, 11 (10), 1518.
S. Berardozzi, F. Bernardi, P. Infante, C. Ingallina, S. Toscano, E. De Paolis, R. Alfonsi, M. Caimano, B. Botta, M. Mori, L. Di Marcotullio, F. Ghirga, Eur. J. Med. Chem. 2018, 156, 554-562.
R. Alfonsi, B. Botta, S. Cacchi, L. Di Marcotullio, G. Fabrizi, R. Faedda, A. Goggiamani, A. Iazzetti, M. Mori, J. Med. Chem. 2017, 60 (4), 1469-1477.
PCT/CN2015/074268, Q. D. A. S. I..
J. Taipale, J. K. Chen, M. K. Cooper, B. Wang, R. K. Mann, L. Milenkovic, M. P. Scott, P. A. Beachy, Nat. Chem. 2000, 406 (6799), 1005-1009.
M. G. Hayden Gephart, Y. S. Su, S. Bandara, F.-C. Tsai, J. Hong, N. Conley, H. Rayburn, L. Milenkovic, T. Meyer, M. P. Scott, J. Neuro-Oncol. 2013, 115, 161-168.
Z.-J. Yang, T. Ellis, S. L. Markant, T.-A. Read, J. D. Kessler, M. Bourboulas, U. Schüller, R. Machold, G. Fishell, D. H. Rowitch, Cancer Cell 2008, 14 (2), 135-145.
FRED 3.3.0.3. OpenEye, C. M. S., Inc., Santa Fe, NM. http://www.eyesopen.com.
B. P. Kelley, S. P. Brown, G. L. Warren, S. W. Muchmore, J. Chem. Inf. Model. 2015, 55 (8), 1771-1780.
M. McGann, J. Chem. Inf. Model. 2011, 51 (3), 578-596.
M. McGann, J. Comput.-Aided Mol. Des. 2012, 26 (8), 897-906.
C. Wang, H. Wu, V. Katritch, G. W. Han, X.-P. Huang, W. Liu, F. Y. Siu, B. L. Roth, V. Cherezov, R. C. Stevens, Nat. Chem. 2013, 497 (7449), 338-343.
P. C. Hawkins, A. G. Skillman, G. L. Warren, B. A. Ellingson, M. T. Stahl, J. Chem. Inf. Model. 2010, 50 (4), 572-584.
OMEGA 3.1.0.3. OpenEye, C. M. S., Santa Fe, NM. http://www.eyesopen.com.
VIDA 4.4.0.4 OpenEye, C. M. S., Santa Fe, NM http://www.eyesopen.com.

Auteurs

Deborah Quaglio (D)

Department of Chemistry and Technology of Drugs, Sapienza University of Rome, P.le Aldo Moro 5, 00185, Rome, Italy.

Paola Infante (P)

Department of Molecular Medicine, Sapienza University of Rome, Viale Regina Elena 291, 00161, Rome, Italy.

Silvia Cammarone (S)

Department of Chemistry and Technology of Drugs, Sapienza University of Rome, P.le Aldo Moro 5, 00185, Rome, Italy.

Lara Lamelza (L)

Department of Chemistry and Technology of Drugs, Sapienza University of Rome, P.le Aldo Moro 5, 00185, Rome, Italy.

Marilisa Conenna (M)

Department of Molecular Medicine, Sapienza University of Rome, Viale Regina Elena 291, 00161, Rome, Italy.

Francesca Ghirga (F)

Department of Chemistry and Technology of Drugs, Sapienza University of Rome, P.le Aldo Moro 5, 00185, Rome, Italy.

Gennaro Adabbo (G)

Department of Molecular Medicine, Sapienza University of Rome, Viale Regina Elena 291, 00161, Rome, Italy.

Luca Pisano (L)

Department of Chemistry and Technology of Drugs, Sapienza University of Rome, P.le Aldo Moro 5, 00185, Rome, Italy.

Lucia Di Marcotullio (L)

Department of Molecular Medicine, Sapienza University of Rome, Viale Regina Elena 291, 00161, Rome, Italy.
Istituto Pasteur-Fondazione Cenci Bolognetti, Sapienza University of Rome, Viale Regina Elena 291, 00161, Rome, Italy.

Bruno Botta (B)

Department of Chemistry and Technology of Drugs, Sapienza University of Rome, P.le Aldo Moro 5, 00185, Rome, Italy.

Mattia Mori (M)

Department of Biotechnology, Chemistry and Pharmacy, University of Siena, Via Aldo Moro 2, 53100, Siena, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH